May 1, 2020 / 7:06 AM / a month ago

BRIEF-Shield Therapeutics Closes London And Newcastle Offices

May 1 (Reuters) - Shield Therapeutics PLC:

* CLOSED BOTH OUR LONDON AND NEWCASTLE OFFICES

* CONTINUING TO DEVOTE SIGNIFICANT EFFORT TO SECURE A COMMERCIALISATION PARTNER FOR USA

* ASK PHARMA, OUR PARTNER IN CHINA, WAS ABLE TO CONTINUE WORKING WITH US DURING LOCKDOWN IN CHINA

* OUR CONTRACT MANUFACTURING PARTNERS CONTINUE TO MANUFACTURE FERACCRU FOR US WITHOUT DISRUPTION

* UNAUDITED REVENUES FOR 2019 ARE NOW EXPECTED TO BE £0.7 MILLION

* UNAUDITED CASH BALANCES AT 31 MARCH 2020 AMOUNTED TO £11.3 MILLION AND GROUP’S CASH RUNWAY EXTENDS INTO Q1 OF 2021. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below